Replicate Pilot study [Power / Sample Size]

posted by ElMaestro  – Denmark, 2014-04-11 12:27 (4453 d 15:55 ago) – Posting: # 12809
Views: 16,296

Hi Kumarnaidu,

❝ Cmax-62.57(38.27 - 102.29) CV-83.85

❝ AUCt-46.09(17.47 - 121.55) CV-263.48

❝ As per experts study failed drastically because of its design (2x2 cross over), and replicate design should be used here instead of 2x2 design.

❝ In my opinion there may be design issue but the test product is also not upto the mark. Please provide your suggestions. Is there a need of change in design of pilot study or test product modification?


Your estimate of CV's is conditional on the point estimates and thus GMR. If you believe in the CV's you believe in the GMRs. If you don't believe in either then I guess you should have a reason. Technical error during bioanalysis etc etc.
To me, as long as concerns over technical errors etc have not been raised, this just looks like a clear-cut failed development to me. I would not spend as much as $.02 on further studies on the present formulation.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
132 visitors (0 registered, 132 guests [including 31 identified bots]).
Forum time: 04:23 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5